The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).

South Africa-linked Anglo American is delivering new platinum group metals (PGM)-catalysed hydrogen-powered fuel cell ...

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

Prof. Bozhi Tian of the University of Chicago is on the frontier of bioelectronics, building living machines that can heal, ...

Scientists have traced the evolutionary origin of humans' outer ears to the gills of ancient fish through a series of gene-editing experiments.

How the Great Rewiring of Childhood Is Causing an Epidemic of Mental Illness has set off alarms and panic from local school ...

Any product that contains cell-cultured protein without being clearly labeled as “cell-cultured” or “lab-grown” would be ...

An international collaboration has achieved an important breakthrough in understanding the genetic mechanisms that allow ...

During his inauguration speech Monday, President Trump promised to make America binary again.

Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...

Zai Lab Limited (ZLAB) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation or ODD to ZL-1310, a ...

Copper chelation shows promising results in certain lung cancers where cells have two related phenomena: a heightened transcription factor responding to oxidative stress and a diminished level of ...